Kavli Institute for Nanoscience Discovery, University of Oxford
Kavli Institute for Nanoscience Discovery is a University of Oxford research hub founded in 2021 that applies physical-science instrumentation — native mass spectrometry, cryo-EM, mass photometry, and NMR — to proteins and nucleic acids, serving seven Oxford departments and funded by major UK and international research grants.
- Company typePrivate
- Founded2021
- HeadquartersOxford, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Kavli Institute for Nanoscience Discovery, University of Oxford does
The Kavli Institute for Nanoscience Discovery (Kavli INsD) is a research institute within the University of Oxford, established in April 2021 and housed in the Dorothy Crowfoot Hodgkin Building on South Parks Road, Oxford. It operates as a hub connecting seven University departments spanning medical and physical sciences, bringing physical-science instrumentation and methods to bear on biological problems at the nanoscale — primarily the structure, interactions, and dynamics of proteins and nucleic acids. Core technical capabilities include native mass spectrometry, cryo-electron microscopy, mass photometry, NMR spectroscopy, and single-molecule imaging, supplemented by proprietary methods such as the open-source precisION workflow for native top-down mass spectrometry and the CryoSeek structure-first discovery paradigm.
The institute's outputs are research discoveries, trained researchers, publications, and shared-facility access rather than commercial products. It is led by Founding Director Professor Dame Carol Robinson and Co-Deputy Director Professor Dame Molly Stevens, with principal investigators, associate professors, research fellows, postdoctoral researchers, and doctoral students organized across Oxford departments. Recent research outcomes include antibody combinations blocking over 90% of malaria parasite growth, identification of the SLC45A4 pain gene, low-cost rapid tests for toxic medicinal syrup contaminants and heat-damaged vaccines, and development of next-generation microrobots with the University of Michigan.
Kavli INsD does not commercialize products or services. Its funding model is grant-driven, with major inflows from Wellcome Trust, UKRI MRC, BBSRC, ERC, UKRI Innovate UK, the Kavli Foundation (USA), and disease-specific charities including Alzheimer's Society, Parkinson's UK, and British Heart Foundation. Notable recent funding includes a £15.9 million joint MRC/Wellcome/Innovate UK award for human in vitro pain models, a nearly £4 million Wellcome Discovery Award for malaria research, and a £3.8 million Wellcome Collaborative Award supporting the Oxford Parkinson's Disease Centre. The institute disseminates work through peer-reviewed publications, the annual Kavli Oxford Lecture Awards, K.R.E.D. lectures, and the Innovation page linking to spin-out companies.
Kavli Institute for Nanoscience Discovery, University of Oxford firmographics
Firmographics- Name
- Kavli Institute for Nanoscience Discovery, University of Oxford
- Legal name
- The University of Oxford
- Website
- https://kavlinano.ox.ac.uk
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kavli Institute for Nanoscience Discovery is a University of Oxford research hub founded in 2021 that applies physical-science instrumentation — native mass spectrometry, cryo-EM, mass photometry, and NMR — to proteins and nucleic acids, serving seven Oxford departments and funded by major UK and international research grants.
- Ownership category
- akta.pro rank
Kavli Institute for Nanoscience Discovery, University of Oxford industry classification
Industry- Product category
- Nanoscience Research
- NAICS
- Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industries
- Engineering & Technology Institutes (Comprehensive) (EDAHAEAA), Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA), Scientific & Laboratory Reference (Chemistry, Biology, Physics; Methods & Protocols) (EDAGAGAG)
Keywords
Where Kavli Institute for Nanoscience Discovery, University of Oxford is headquartered
LocationHeadquarters
- HQ city
- Oxford
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Kavli Institute for Nanoscience Discovery, University of Oxford business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Research Grant Funding: Competitive grant funding from major research councils and charitable foundations including Wellcome Trust, Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC), European Research Council (ERC), UKRI, and disease-specific charities such as Alzheimer's Society, Parkinson's UK, and British Heart Foundation.
- Kavli Foundation Support: Funding from the Kavli Foundation, USA ($250,000 awarded in late 2024) to support establishment of an Ethics Hub embedded within Kavli Oxford.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Kavli Institute for Nanoscience Discovery, University of Oxford product offering
Product offeringCore offering
The Kavli Institute for Nanoscience Discovery is a university research institute that conducts interdisciplinary nanoscience discovery research, bringing together physical sciences and cellular biology to study proteins and nucleic acids at the nanoscale. The institute provides shared state-of-the-art research facilities, training, and collaborative research programs across seven departments spanning medical and physical sciences at the University of Oxford.
Product overview
The Kavli Institute for Nanoscience Discovery is a university research hub that brings together physical sciences and life sciences to conduct curiosity-driven research in nanoscience. Rather than offering commercial products, the Institute provides shared research facilities, collaborative research programs, and academic lecture series (including the Kavli Oxford Lecture Awards and K.R.E.D. discussions) to support interdisciplinary scientific discovery. Research areas span from developing new instrumentation to addressing major health challenges including malaria, neurodegenerative diseases, and vaccine development.
Differentiator
Problem solved
Functional benefit
Brands
- Kavli Oxford Lecture Award: Annual lecture award recognizing scientific leadership characterized by curiosity-driven research, interdisciplinary thinking, and commitment to translating fundamental discoveries into real-world benefits
- Kavli Research and Enterprise Discussions (K.R.E.D)
Products and services
- Kavli INsD Shared Research Facilities
- Research Collaboration Programs
- precisION Software
Quantifiable outcome
- Antibody combinations blocking over 90% of malaria parasite growth discovered
- +2 more outcomes
Companies that use Kavli Institute for Nanoscience Discovery, University of Oxford
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
Kavli Institute for Nanoscience Discovery, University of Oxford technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Kavli Institute for Nanoscience Discovery, University of Oxford partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and major.
- Kavli Institute for Nanoscience DelftcorePart of the global Kavli Institute network. Professor Gijsje Koenderink from TU Delft (Co-director of Kavli Delft) gave K.R.E.D. lecture on bottom-up synthetic biology at Kavli Oxford.
- Vaccine Identify Evaluation (VIE) CollaborationcoreCross-institutional effort involving researchers from across the University of Oxford, healthcare, academia, and industry to demonstrate that hospital analysers can identify falsified vaccines.
- Oxford University Hospitals NHS Foundation TrustmajorCo-lead of the study on using hospital analysers to identify falsified vaccines. Professor Tim James from OUH NHS FT is co-lead.
- University of Oxford Department of BiochemistrycoreInterdisciplinary collaboration between Kavli Oxford researchers and the Department of Biochemistry to develop rapid, low-cost tests (<£1 per test) for detecting toxic contaminants in medicinal syrups. Published in Scientific Reports.
- Kavli Energy NanoSciences Institute, UC BerkeleycoreKavli Institute network collaboration. Professor Dame Carol Robinson delivered Kavli Distinguished Lecture at Berkeley. Discussion of synergies between Kavli Berkeley and Kavli Oxford.
- Oxford-Harrington Rare Disease CentrecorePartnership between University of Oxford and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio. Professor Esther Becker received 2025 Rare Disease Scholar Award (£100,000) and FA Alliance Innovation Fund support.
- University of MichigancoreCollaboration between Kavli Oxford's Stevens Group and Professor Sharon Glotzer's team at University of Michigan for development of next-generation microrobots for targeted therapy.
- Nuffield Department of Clinical NeurosciencescorePartner department in the £15.9 million human in vitro pain models initiative. Professor Zameel Cader leads one of five interdisciplinary teams.
- The Kennedy Institute of RheumatologycorePartner department in the £15.9 million human in vitro pain models initiative, bringing expertise in inflammation research.
- Department of Engineering Science, OxfordcorePartner department in the £15.9 million human in vitro pain models initiative, contributing engineering and bioengineering expertise.
- Medicines Discovery CatapultmajorIndustry partner in the £15.9 million human in vitro pain models initiative, bridging academic research with pharmaceutical industry.
- MaxWell BioSystemsmajorIndustry partner in the £15.9 million human in vitro pain models initiative, contributing expertise in bio-systems technology.
- Royal Veterinary CollegecoreCollaborating institution for Professor Matt Higgins' Wellcome Discovery Award (£4 million over 8 years) on malaria parasite erythrocyte invasion.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Kavli Institute for Nanoscience Discovery, University of Oxford competitors and assessment
Company assessmentDirect peers
- Whitehead Institute for Biomedical Research: MIT-affiliated biomedical research institute with small faculty conducting high-impact fundamental research. Comparable in scale, mission, and operating model of a focused research institute within a larger university.
- Francis Crick Institute: Major UK biomedical discovery institute with interdisciplinary research across the life sciences. Comparable in mission (fundamental biomedical discovery), funding body (Wellcome, MRC, Cancer Research UK), and organizational structure as a multi-departmental research hub.
- Janelia Research Campus (HHMI): HHMI's discovery-focused research campus emphasizing tool development and interdisciplinary collaboration. Comparable in model of bringing together physical sciences, engineering, and biology for fundamental discovery research.
- Broad Institute of MIT and Harvard: Leading US biomedical and genomic research institute focused on interdisciplinary science and translational impact. Comparable in operating model, scale of grant funding, and emphasis on bringing together physical/computational approaches with biomedical research.
- Wellcome Sanger Institute: UK genomics and biomedical research institute funded primarily by Wellcome Trust. Comparable in funding base, mission of large-scale biomedical discovery, and connected through the same Wellcome funding ecosystem.
- Kavli Institute of Nanoscience Delft: Sister Kavli Institute at TU Delft also operating under the global Kavli network for nanoscience research. Comparable mandate and Kavli Foundation relationship, with active cross-institutional collaborations documented in the data.
- Kavli Energy NanoScience Institute (UC Berkeley): Sister Kavli Institute under the same Kavli Foundation network, focused on nanoscience at the intersection of physical and biological sciences. Directly comparable organizational structure, funding relationships, and research approach.
- MRC Laboratory of Molecular Biology: UK-based biomedical research institute operating at the intersection of molecular biology and physical/structural sciences. Highly comparable to Kavli INsD in mission, scale, and reliance on competitive grant funding from MRC and Wellcome.
- Max Planck Institute for Molecular Genetics: German research institute conducting molecular and genome-focused research with strong emphasis on international collaboration. Comparable in fundamental research mission, public/non-profit funding model, and publishing-driven outputs.
Regional players
- Medical Research Council (MRC) - Human Genetics Unit: UK research unit within the University of Edinburgh focused on human genetics and molecular medicine. Comparable in being a publicly funded MRC research unit embedded in a UK university with biomedical discovery focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks4 records
Key highlights7 records
Customer concentration
Kavli Institute for Nanoscience Discovery, University of Oxford social profiles
Digital presenceKavli Institute for Nanoscience Discovery, University of Oxford financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kavli Institute for Nanoscience Discovery, University of Oxford leadership team
Management profileNumber of profiles
Profiles7 records
Kavli Institute for Nanoscience Discovery, University of Oxford funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kavli Institute for Nanoscience Discovery, University of Oxford M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kavli Institute for Nanoscience Discovery, University of Oxford
What does Kavli Institute for Nanoscience Discovery, University of Oxford do?
The Kavli Institute for Nanoscience Discovery is a university research institute that conducts interdisciplinary nanoscience discovery research, bringing together physical sciences and cellular biology to study proteins and nucleic acids at the nanoscale. The institute provides shared state-of-the-art research facilities, training, and collaborative research programs across seven departments spanning medical and physical sciences at the University of Oxford.
Is Kavli Institute for Nanoscience Discovery, University of Oxford a public or private company?
Kavli Institute for Nanoscience Discovery, University of Oxford is a private company. It is classified as state government owned and is currently operating.
When was Kavli Institute for Nanoscience Discovery, University of Oxford founded?
Kavli Institute for Nanoscience Discovery, University of Oxford was founded in 2021. It employs 11 to 50 people.
Where is Kavli Institute for Nanoscience Discovery, University of Oxford based?
Kavli Institute for Nanoscience Discovery, University of Oxford is headquartered in Oxford, United Kingdom, in the Europe region.
How does Kavli Institute for Nanoscience Discovery, University of Oxford make money?
Two revenue lines are on record. Research Grant Funding is the primary driver. The others are kavli Foundation Support.
Who are Kavli Institute for Nanoscience Discovery, University of Oxford's main competitors?
Direct peers on record are Whitehead Institute for Biomedical Research, Francis Crick Institute, Janelia Research Campus (HHMI), Broad Institute of MIT and Harvard, Wellcome Sanger Institute, Kavli Institute of Nanoscience Delft, Kavli Energy NanoScience Institute (UC Berkeley), MRC Laboratory of Molecular Biology and Max Planck Institute for Molecular Genetics. Medical Research Council (MRC) - Human Genetics Unit is listed as a regional player.
Does Kavli Institute for Nanoscience Discovery, University of Oxford have an API?
No public API is recorded for Kavli Institute for Nanoscience Discovery, University of Oxford.
What industry is Kavli Institute for Nanoscience Discovery, University of Oxford in?
Kavli Institute for Nanoscience Discovery, University of Oxford's product category is Nanoscience Research. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAHAEAA, Engineering & Technology Institutes (Comprehensive). Its NAICS code is 541713 and its SIC code is 8731.